132
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

A cryptic submicroscopic deletion of 5’ MLF1–3’ NPM1 segment on derivative chromosome 3 in a patient with acute myeloid leukemia with t(3;5)(q25;q35)

, , , , , , , , , & show all
Pages 2735-2738 | Received 15 Jul 2014, Accepted 09 Jan 2015, Published online: 11 Feb 2015

References

  • Bacher U, Schnittger S, Kern W, et al. The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia. Haematologica 2005;90:558–559.
  • Moon HW, Chang YH, Kim TY, et al. Incidence of submicroscopic deletions vary according to disease entities and chromosomal translocations in hematologic malignancies: investigation by fluorescence in situ hybridization. Cancer Genet Cytogenet 2007; 175:166–168.
  • Lee YK, Kim YR, Min HC, et al. Deletion of any part of the BCR or ABL gene on the derivative chromosome 9 is a poor prognostic marker in chronic myelogenous leukemia. Cancer Genet Cytogenet 2006;166:65–73.
  • Godon C, Proffitt J, Dastugue N, et al. Large deletions 5’ to the ETO breakpoint are recurrent events in patients with t(8;21) acute myeloid leukemia. Leukemia 2002;16:1752–1754.
  • Egan N, O’Reilly J, Chipper L, et al. Deletion of CBFB in a patient with acute myelomonocytic leukemia (AML M4Eo) and inversion 16. Cancer Genet Cytogenet 2004;154:60–62.
  • Arber DA, Chang KL, Lyda MH, et al. Detection of NPM/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasia. Hum Pathol 2003;34:809–813.
  • Berger R, Busson M, Baranger L, et al. Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements. Leukemia 2006;20:319–321.
  • Shaffer LG, Slovak ML, Campbell LJ. ISCN 2009: an international system for human cytogenetic nomenclature (2009). Basel: Karger Medical Scientific; 2009.
  • Grisendi S, Bernardi R, Rossi M, et al. Role of nucleophosmin in embryonic development and tumorigenesis. Nature 2005;437: 147–153.
  • Dumezy F, Renneville A, Mayeur-Rousse C, et al. Acute myeloid leukemia with translocation t(3;5): new molecular insights. Haematologica 2013;98:e52–e54.
  • Lee WH, Salek-Ardakani S, Pandolfi PP, et al. NPM-MLF1 synergizes with Npm haploinsufficiency to enhance myeloid progenitor activity. Leukemia 2012;26:1110–1112.
  • Matsumoto N, Yoneda-Kato N, Iguchi T, et al. Elevated MLF1 expression correlates with malignant progression from myelodysplastic syndrome. Leukemia 2000;14:1757–1765.
  • Schmidt B, Liebenberg V, Dietrich D, et al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer 2010;10:600.
  • Kneip C, Schmidt B, Seegebarth A, et al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. J Thorac Oncol 2011;6:1632–1638.
  • Peng L, Yanjiao M, Ai-guo W, et al. A fine balance between CCNL1 and TIMP1 contributes to the development of breast cancer cells. Biochem Biophys Res Commun 2011;409:344–349.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.